Germany Records 1st Death by Omicron

The Robert Koch Institute reported the first death by the newly emerged variant, Omicron, Al-Ain reported on Thursday. The dead is an 80-year old man.

In the same context, several vaccine makers still studying the impact of the new mutation and the vaccines' efficiency.

A new study by Oxford University showed that three doses of the Oxford-AstraZeneca vaccine are effective against Omicron.

Moreover, AstraZeneca revealed that it is working on developing a vaccine for the recent strain variant with Oxford.

“Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed and will be informed by emerging data,” AstraZeneca’s Spokesperson said in a statement.

Moreover, several drug makers selected booster shot solutions to strengthen the impact of the vaccines in providing protection against the recently emerged strain.

In the same context, corporations started to test the impact of the Omicron variant on available vaccines such as Pfizer, and Sputnik.